Shigellosis pathophysiology: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
m (Changes made per Mahshid's request)
 
(23 intermediate revisions by one other user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Shigellosis}}
{{Shigellosis}}
{{CMG}} '''Associate Editor(s)-In-Chief:''' [[User:YazanDaaboul|Yazan Daaboul]]; [[User:Sergekorjian|Serge Korjian]]
==Overview==
==Overview==
A small inoculum of ''Shigella'' (10 to 200 organisms) is sufficient to cause shigellosis. ''Shigella'' is commonly spread by the [[fecal-oral route]] in regions of poor sanitation (foodborne or waterborne transmission). Shigella first invades the [[epithelial cell]]s of the [[large intestine]] by using [[M cell]]s as entry ports for [[transcytosis]]. Shigella then invades [[macrophage]]s and induces cellular [[apoptosis]], which results in [[inflammation]], generation of [[proinflammatory cytokine]]s, and recruitment of [[polymorphonuclear neutrophil]]s (PMNs). Following transcytosis and macrophage apoptosis, ''Shigella'' avoids extracellular exposure and spreads intercellularly using [[actin polymerization]] processes (rocket propulsion). As PMN invade the site of active inflammation, the integrity of the intestinal epithelial barrier is lost, and adsorption of fluids and nutrients is impaired, resulting in clinical manifestations of shigellosis (e.g. [[diarrhea]]). On gross pathology, [[hyperemia]] with development of [[ulcer]]s and [[edema]] are typical findings. On microscopic pathology, infiltration of PMN and inflammatory [[pseudomembrane]]s are characteristic features.
==Pathophysiology==
==Pathophysiology==
===Transmission===
===Transmission===
*A small inoculum (10 to 200 organisms) is sufficient to cause shigellosis.  
*A small inoculum of ''Shigella'' (10 to 200 organisms) is sufficient to cause shigellosis.<ref name="pmid2656880">{{cite journal| author=DuPont HL, Levine MM, Hornick RB, Formal SB| title=Inoculum size in shigellosis and implications for expected mode of transmission. | journal=J Infect Dis | year= 1989 | volume= 159 | issue= 6 | pages= 1126-8 | pmid=2656880 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2656880  }} </ref>
*Most commonly, shigella is reported to be easily spread by the fecal-oral route in regions of poor sanitation.
*''Shigella'' is commonly spread by the fecal-oral route in regions with poor sanitation.<ref name="pmid2656880">{{cite journal| author=DuPont HL, Levine MM, Hornick RB, Formal SB| title=Inoculum size in shigellosis and implications for expected mode of transmission. | journal=J Infect Dis | year= 1989 | volume= 159 | issue= 6 | pages= 1126-8 | pmid=2656880 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2656880  }} </ref><ref name="pmid18202440">{{cite journal| author=Schroeder GN, Hilbi H| title=Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion. | journal=Clin Microbiol Rev | year= 2008 | volume= 21 | issue= 1 | pages= 134-56 | pmid=18202440 | doi=10.1128/CMR.00032-07 | pmc=PMC2223840 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18202440  }} </ref>
*Epidemics may be foodborne or waterborne.
*Exposure to contaminated food (e.g. vegetables or meat) or water (drinking or swimming in untreated water) is associated with shigellosis. Contaminated food and water may have a normal appearance and smell.
*Shigella can also be transmitted by flies and sexual contact.
*Epidemics may be [[foodborne]] or [[waterborne]].<ref name="pmid2656880">{{cite journal| author=DuPont HL, Levine MM, Hornick RB, Formal SB| title=Inoculum size in shigellosis and implications for expected mode of transmission. | journal=J Infect Dis | year= 1989 | volume= 159 | issue= 6 | pages= 1126-8 | pmid=2656880 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2656880  }} </ref>
*Shigella can also be transmitted by flies and sexual contact.<ref name="pmid18202440">{{cite journal| author=Schroeder GN, Hilbi H| title=Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion. | journal=Clin Microbiol Rev | year= 2008 | volume= 21 | issue= 1 | pages= 134-56 | pmid=18202440 | doi=10.1128/CMR.00032-07 | pmc=PMC2223840 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18202440  }} </ref>


===Microscopic Pathology==
===Cellular Pathogenesis===
The small inoculum may be attributed to the following features of the organism:
The small inoculum may be attributed to the following features of the organism:
*''Shigella'' contains acid resistance systems that enable the organism to survive the acidic environment in the stomach.(61)
*''Shigella'' contains acid resistance systems that enable the organism to survive the acidic environment in the [[stomach]].<ref name="pmid8418063">{{cite journal| author=Gorden J, Small PL| title=Acid resistance in enteric bacteria. | journal=Infect Immun | year= 1993 | volume= 61 | issue= 1 | pages= 364-7 | pmid=8418063 | doi= | pmc=PMC302732 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8418063  }} </ref>
*''Shigella'' can downregulate the expresion of antibacterial proteins released by the host (human) intestinal mucosa.(118)
*''Shigella'' can downregulate the expression of antibacterial proteins released by the host (human) [[intestinal mucosa]].<ref name="pmid11175848">{{cite journal| author=Islam D, Bandholtz L, Nilsson J, Wigzell H, Christensson B, Agerberth B et al.| title=Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. | journal=Nat Med | year= 2001 | volume= 7 | issue= 2 | pages= 180-5 | pmid=11175848 | doi=10.1038/84627 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11175848  }} </ref>


====Phase 1:Transcytosis Using M Cells As Entry Ports===
====Phase 1:Transcytosis Using M Cells As Entry Ports====
''Shigella'' migrates to the large intestine, where it causes infection via invasion of the epithelial barrier of the large intestine. Initially, ''Shigella'' uses M cells from the basolateral side of the intestinal epithelium as entry port.(250,325) M cells are specialized cells that sample the gut lumen for pathogenic antigens and delivers these antigens to mucosal lymphoid tissue to activate an adequate immune response.(157). ''Shigella'' is transcytosed across the epithelial layer of the intestinal M cells.  
''Shigella'' migrates to the [[large intestine]], where it causes infection via invasion of the epithelial barrier of the large intestine. Initially, ''Shigella'' uses [[M cell]]s from the basolateral side of the intestinal epithelium as entry port.<ref name="pmid2645214">{{cite journal| author=Wassef JS, Keren DF, Mailloux JL| title=Role of M cells in initial antigen uptake and in ulcer formation in the rabbit intestinal loop model of shigellosis. | journal=Infect Immun | year= 1989 | volume= 57 | issue= 3 | pages= 858-63 | pmid=2645214 | doi= | pmc=PMC313189 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2645214  }} </ref> M cells are specialized cells that sample the gut lumen for pathogenic antigens and delivers these antigens to mucosal [[lymphoid tissue]] to activate an adequate [[immune response]].<ref name="pmid15312131">{{cite journal| author=Man AL, Prieto-Garcia ME, Nicoletti C| title=Improving M cell mediated transport across mucosal barriers: do certain bacteria hold the keys? | journal=Immunology | year= 2004 | volume= 113 | issue= 1 | pages= 15-22 | pmid=15312131 | doi=10.1111/j.1365-2567.2004.01964.x | pmc=PMC1782554 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15312131  }} </ref> ''Shigella'' is [[transcytosed]] across the epithelial layer of the intestinal M cells.  


====Phase 2:Uptake by Macrophages====
====Phase 2:Uptake by Macrophages====
*Following transcytosis, ''Shigella'' enters macrophages and induces cellular apoptosis.
*Following transcytosis, ''Shigella'' enters macrophages and induces cellular [[apoptosis]].<ref name="pmid1614548">{{cite journal| author=Zychlinsky A, Prevost MC, Sansonetti PJ| title=Shigella flexneri induces apoptosis in infected macrophages. | journal=Nature | year= 1992 | volume= 358 | issue= 6382 | pages= 167-9 | pmid=1614548 | doi=10.1038/358167a0 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1614548  }} </ref>
*Macrophage apoptosis results in the release of pro-inflammatory cytokines (IL-1-beta and IL-18)), which signal intestinal inflammation and consequent innate immune response.
*Macrophage apoptosis results in the release of [[proinflammatory cytokine]]s (IL-1-beta and IL-18), which signal intestinal inflammation and consequent activation of the [[innate immune system]].<ref name="pmid8083373">{{cite journal| author=Zychlinsky A, Fitting C, Cavaillon JM, Sansonetti PJ| title=Interleukin 1 is released by murine macrophages during apoptosis induced by Shigella flexneri. | journal=J Clin Invest | year= 1994 | volume= 94 | issue= 3 | pages= 1328-32 | pmid=8083373 | doi=10.1172/JCI117452 | pmc=PMC295219 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8083373  }} </ref><ref name="pmid10843390">{{cite journal| author=Sansonetti PJ, Phalipon A, Arondel J, Thirumalai K, Banerjee S, Akira S et al.| title=Caspase-1 activation of IL-1beta and IL-18 are essential for Shigella flexneri-induced inflammation. | journal=Immunity | year= 2000 | volume= 12 | issue= 5 | pages= 581-90 | pmid=10843390 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10843390  }} </ref>


====Phase 3: Release from Apoptotic Macrophages====
====Phase 3: Release from Apoptotic Macrophages====
*Following apoptosis and inflammation, ''Shigella'' is released from the macrophages.
*Following apoptosis and inflammation, ''Shigella'' is released from the macrophages.<ref name="pmid3510976">{{cite journal| author=Sansonetti PJ, Ryter A, Clerc P, Maurelli AT, Mounier J| title=Multiplication of Shigella flexneri within HeLa cells: lysis of the phagocytic vacuole and plasmid-mediated contact hemolysis. | journal=Infect Immun | year= 1986 | volume= 51 | issue= 2 | pages= 461-9 | pmid=3510976 | doi= | pmc=PMC262354 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3510976  }} </ref>
*Invasion of the intestinal epithelium continues from the basolateral side, and the bacteria further spreads to adjacent epithelial cells and avoids extracellular exposure by using intercellular actin polymerization processes.
*Invasion of the intestinal epithelium continues from the basolateral side, and the bacteria further spreads to adjacent epithelial cells and avoids extracellular exposure by using intercellular [[actin polymerization]] processes (rocket propulsion).<ref name="pmid2542950">{{cite journal| author=Bernardini ML, Mounier J, d'Hauteville H, Coquis-Rondon M, Sansonetti PJ| title=Identification of icsA, a plasmid locus of Shigella flexneri that governs bacterial intra- and intercellular spread through interaction with F-actin. | journal=Proc Natl Acad Sci U S A | year= 1989 | volume= 86 | issue= 10 | pages= 3867-71 | pmid=2542950 | doi= | pmc=PMC287242 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2542950  }} </ref>


====Infiltration of Polymorphonuclear Neutrophils====
====Phase 4: Infiltration of Polymorphonuclear Neutrophils====
*As ''Shigella'' infiltrates the epithelial cells, activation of nuclear factor kappa-B (NF-KB) by ''Shigella'' generates IL-8, which in turn mediates the recruitment of polymorphonuclear neutrophils (PMN) to the site of inflammation.  
*As ''Shigella'' infiltrates the epithelial cells, activation of nuclear factor kappa-B (NF-KB) by ''Shigella'' generates [[IL-8]], which in turn mediates the recruitment of polymorphonuclear neutrophils (PMN) to the site of inflammation.<ref name="pmid12791997">{{cite journal| author=Girardin SE, Boneca IG, Carneiro LA, Antignac A, Jéhanno M, Viala J et al.| title=Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. | journal=Science | year= 2003 | volume= 300 | issue= 5625 | pages= 1584-7 | pmid=12791997 | doi=10.1126/science.1084677 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12791997  }} </ref>
*PMN destroy the integrity of the intestinal epithelial barrier and allow more ''Shigella'' organisms to directly and more easily invade the intestinal epithelium. The loss of the intestinal epithelial cells results in impaired adsorption of other nutrients and fluids and leads to clinical manifestations of shigellosis (diarrhea).
*PMN destroy the integrity of the intestinal epithelial barrier and allow more ''Shigella'' organisms to directly and more easily invade the intestinal epithelium. The loss of the intestinal epithelial cells results in impaired adsorption of other nutrients and fluids and leads to clinical manifestations of shigellosis (diarrhea).<ref name="pmid18202440">{{cite journal| author=Schroeder GN, Hilbi H| title=Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion. | journal=Clin Microbiol Rev | year= 2008 | volume= 21 | issue= 1 | pages= 134-56 | pmid=18202440 | doi=10.1128/CMR.00032-07 | pmc=PMC2223840 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18202440  }} </ref>
*''Shigella enterotoxin 1 (ShET1) and enterotoxin 2 (ShET2) are synthesized during the inflammatory process and are thought to account, at least in part, for fluid secretion that results in shigellosis-associated diarrhea.
*''Shigella'' enterotoxin 1 (ShET1) and enterotoxin 2 (ShET2) are synthesized during the inflammatory process and are thought to account, at least in part, for fluid secretion that results in shigellosis-associated diarrhea.<ref name="pmid9176079">{{cite journal| author=Fasano A, Noriega FR, Liao FM, Wang W, Levine MM| title=Effect of shigella enterotoxin 1 (ShET1) on rabbit intestine in vitro and in vivo. | journal=Gut | year= 1997 | volume= 40 | issue= 4 | pages= 505-11 | pmid=9176079 | doi= | pmc=PMC1027126 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9176079  }} </ref>
*Other Shigella toxins, such as ''Shigella dysenteriae'' serotype 1 toxin, results in cytotoxicity and development of vascular lesions at the level of the colon, the kidneys, and the central nervous system. The cytotoxic activity of the toxin is thought to cause shigella-associated complications, such as hemolytic uremic syndrome (HUS).
*Other Shigella toxins, such as ''Shigella dysenteriae'' serotype 1 toxin, results in cytotoxicity and development of vascular lesions at the level of the colon, the kidneys, and the central nervous system. The cytotoxic activity of the toxin is thought to cause shigella-associated complications, such as hemolytic uremic syndrome (HUS).<ref name="pmid14638419">{{cite journal| author=Cherla RP, Lee SY, Tesh VL| title=Shiga toxins and apoptosis. | journal=FEMS Microbiol Lett | year= 2003 | volume= 228 | issue= 2 | pages= 159-66 | pmid=14638419 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14638419  }} </ref>
Ultimately, more PMN are recruited and ''Shigella'' organisms are killed.
Ultimately, more PMNs are recruited and ''Shigella'' organisms are killed.


===Genetics===
===Associated Conditions===
===Gross Pathology===
===Gross Pathology===
===Microscopic Pathology===''Shigella'' infection is typically via ingestion (fecal–oral contamination); depending on age and condition of the host as few as ten bacterial cells can be enough to cause an infection. ''Shigella'' cause [[dysentery]] that results in the destruction of the epithelial cells of the intestinal mucosa in the [[cecum]] and [[rectum]]. Some strains produce [[enterotoxin]] and [[Shiga toxin]], similar to the [[verotoxin]] of [[Escherichia coli O157 H7|''E. coli'' O157:H7]].<ref>{{cite book | author =  Hale TL, Keusch GT | title = Shigella. ''in:'' Baron's Medical Microbiology ''(Baron S ''et al'', eds.)| edition = 4th ed. | publisher = Univ of Texas Medical Branch | year = 1996 | url = http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=mmed.chapter.1257 | isbn =  0-9631172-1-1 }}</ref> Both Shiga toxin and verotoxin are associated with causing [[hemolytic uremic syndrome]].
On gross pathology, shigellosis is typically associated with acute-onset diffuse [[fibrinous]] [[exudative]] [[inflammation]] in the [[colon]] and/or the [[rectum]]. The following histopathological features may be observed:
*Ulcer formation and focal erosions
*[[Necrotizing inflammation]]
*[[Hyperemia]]
*[[Edema]]


''Shigella'' invade the host through [[epithelial cell]]s of the [[small intestine]]. Using a Type III secretion system acting as a biological syringe, the bacterium injects ''Ipa'' protein into cell, triggering bacterial invasion, and the subsequently [[lysis]] of [[Vacuole|vacuolar]] membranes. It utilizes a mechanism for its motility by which its IcsA triggers actin polymerization in the host cell in a "rocket" propulsion fashion for cell-to-cell spread.
===Microscopic Pathology===
 
On microscopic histopathological analysis, the following findings may be observed from samples of the colon, rectum, and occasionally the distal ileum:
The most common symptoms are diarrhea, fever, nausea, vomiting, stomach cramps, and straining to have a bowel movement. The stool may contain blood, mucus, or pus (e.g. dysentery). In rare cases, young children may have [[seizure]]s. Symptoms can take as long as a week to show up, but most often begin two to four days after ingestion. Symptoms usually last for several days, but can last for weeks. Shigella is implicated as one of the pathogenic causes of [[reactive arthritis]] worldwide.<ref>{{cite journal |author=Hill Gaston JS, Lillicrap MS |title=Arthritis associated with enteric infection |journal=Best practice & research. Clinical rheumatology |volume=17 |issue=2 |pages=219-39 |year=2003 |pmid=12787523 |doi=}}</ref>
*[[PMN infiltration]]
 
*Formation of patchy inflammatory [[pseudomembrane]]
Severe dysentery can be treated with [[ampicillin]], [[Trimethoprim-sulfamethoxazole|TMP-SMX]], or [[fluoroquinolone]]s such as [[ciprofloxacin]].
=== Histopathology of Shigellosis (Bacillary Dysentery)===


The following video demonstrates the microscopic pathological features of shigellosis:
{{#ev:youtube|1D1m4rybDrc}}
{{#ev:youtube|1D1m4rybDrc}}


Line 50: Line 54:
{{Reflist|2}}
{{Reflist|2}}
[[Category:Disease]]
[[Category:Disease]]
[[Category:Infectious disease]]
 
[[Category:Gastroenterology]]
[[Category:Gastroenterology]]
[[Category:Medicine]]
[[Category:Medicine]]

Latest revision as of 19:04, 18 September 2017

Shigellosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Classification

Causes

Differentiating Shigellosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Shigellosis pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Shigellosis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Shigellosis pathophysiology

CDC on Shigellosis pathophysiology

Shigellosis pathophysiology in the news

Blogs on Shigellosis pathophysiology

Directions to Hospitals Treating Shigellosis

Risk calculators and risk factors for Shigellosis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-In-Chief: Yazan Daaboul; Serge Korjian

Overview

A small inoculum of Shigella (10 to 200 organisms) is sufficient to cause shigellosis. Shigella is commonly spread by the fecal-oral route in regions of poor sanitation (foodborne or waterborne transmission). Shigella first invades the epithelial cells of the large intestine by using M cells as entry ports for transcytosis. Shigella then invades macrophages and induces cellular apoptosis, which results in inflammation, generation of proinflammatory cytokines, and recruitment of polymorphonuclear neutrophils (PMNs). Following transcytosis and macrophage apoptosis, Shigella avoids extracellular exposure and spreads intercellularly using actin polymerization processes (rocket propulsion). As PMN invade the site of active inflammation, the integrity of the intestinal epithelial barrier is lost, and adsorption of fluids and nutrients is impaired, resulting in clinical manifestations of shigellosis (e.g. diarrhea). On gross pathology, hyperemia with development of ulcers and edema are typical findings. On microscopic pathology, infiltration of PMN and inflammatory pseudomembranes are characteristic features.

Pathophysiology

Transmission

  • A small inoculum of Shigella (10 to 200 organisms) is sufficient to cause shigellosis.[1]
  • Shigella is commonly spread by the fecal-oral route in regions with poor sanitation.[1][2]
  • Exposure to contaminated food (e.g. vegetables or meat) or water (drinking or swimming in untreated water) is associated with shigellosis. Contaminated food and water may have a normal appearance and smell.
  • Epidemics may be foodborne or waterborne.[1]
  • Shigella can also be transmitted by flies and sexual contact.[2]

Cellular Pathogenesis

The small inoculum may be attributed to the following features of the organism:

  • Shigella contains acid resistance systems that enable the organism to survive the acidic environment in the stomach.[3]
  • Shigella can downregulate the expression of antibacterial proteins released by the host (human) intestinal mucosa.[4]

Phase 1:Transcytosis Using M Cells As Entry Ports

Shigella migrates to the large intestine, where it causes infection via invasion of the epithelial barrier of the large intestine. Initially, Shigella uses M cells from the basolateral side of the intestinal epithelium as entry port.[5] M cells are specialized cells that sample the gut lumen for pathogenic antigens and delivers these antigens to mucosal lymphoid tissue to activate an adequate immune response.[6] Shigella is transcytosed across the epithelial layer of the intestinal M cells.

Phase 2:Uptake by Macrophages

Phase 3: Release from Apoptotic Macrophages

  • Following apoptosis and inflammation, Shigella is released from the macrophages.[10]
  • Invasion of the intestinal epithelium continues from the basolateral side, and the bacteria further spreads to adjacent epithelial cells and avoids extracellular exposure by using intercellular actin polymerization processes (rocket propulsion).[11]

Phase 4: Infiltration of Polymorphonuclear Neutrophils

  • As Shigella infiltrates the epithelial cells, activation of nuclear factor kappa-B (NF-KB) by Shigella generates IL-8, which in turn mediates the recruitment of polymorphonuclear neutrophils (PMN) to the site of inflammation.[12]
  • PMN destroy the integrity of the intestinal epithelial barrier and allow more Shigella organisms to directly and more easily invade the intestinal epithelium. The loss of the intestinal epithelial cells results in impaired adsorption of other nutrients and fluids and leads to clinical manifestations of shigellosis (diarrhea).[2]
  • Shigella enterotoxin 1 (ShET1) and enterotoxin 2 (ShET2) are synthesized during the inflammatory process and are thought to account, at least in part, for fluid secretion that results in shigellosis-associated diarrhea.[13]
  • Other Shigella toxins, such as Shigella dysenteriae serotype 1 toxin, results in cytotoxicity and development of vascular lesions at the level of the colon, the kidneys, and the central nervous system. The cytotoxic activity of the toxin is thought to cause shigella-associated complications, such as hemolytic uremic syndrome (HUS).[14]

Ultimately, more PMNs are recruited and Shigella organisms are killed.

Gross Pathology

On gross pathology, shigellosis is typically associated with acute-onset diffuse fibrinous exudative inflammation in the colon and/or the rectum. The following histopathological features may be observed:

Microscopic Pathology

On microscopic histopathological analysis, the following findings may be observed from samples of the colon, rectum, and occasionally the distal ileum:

The following video demonstrates the microscopic pathological features of shigellosis: {{#ev:youtube|1D1m4rybDrc}}

References

  1. ↑ 1.0 1.1 1.2 DuPont HL, Levine MM, Hornick RB, Formal SB (1989). "Inoculum size in shigellosis and implications for expected mode of transmission". J Infect Dis. 159 (6): 1126–8. PMID 2656880.
  2. ↑ 2.0 2.1 2.2 Schroeder GN, Hilbi H (2008). "Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion". Clin Microbiol Rev. 21 (1): 134–56. doi:10.1128/CMR.00032-07. PMC 2223840. PMID 18202440.
  3. ↑ Gorden J, Small PL (1993). "Acid resistance in enteric bacteria". Infect Immun. 61 (1): 364–7. PMC 302732. PMID 8418063.
  4. ↑ Islam D, Bandholtz L, Nilsson J, Wigzell H, Christensson B, Agerberth B; et al. (2001). "Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator". Nat Med. 7 (2): 180–5. doi:10.1038/84627. PMID 11175848.
  5. ↑ Wassef JS, Keren DF, Mailloux JL (1989). "Role of M cells in initial antigen uptake and in ulcer formation in the rabbit intestinal loop model of shigellosis". Infect Immun. 57 (3): 858–63. PMC 313189. PMID 2645214.
  6. ↑ Man AL, Prieto-Garcia ME, Nicoletti C (2004). "Improving M cell mediated transport across mucosal barriers: do certain bacteria hold the keys?". Immunology. 113 (1): 15–22. doi:10.1111/j.1365-2567.2004.01964.x. PMC 1782554. PMID 15312131.
  7. ↑ Zychlinsky A, Prevost MC, Sansonetti PJ (1992). "Shigella flexneri induces apoptosis in infected macrophages". Nature. 358 (6382): 167–9. doi:10.1038/358167a0. PMID 1614548.
  8. ↑ Zychlinsky A, Fitting C, Cavaillon JM, Sansonetti PJ (1994). "Interleukin 1 is released by murine macrophages during apoptosis induced by Shigella flexneri". J Clin Invest. 94 (3): 1328–32. doi:10.1172/JCI117452. PMC 295219. PMID 8083373.
  9. ↑ Sansonetti PJ, Phalipon A, Arondel J, Thirumalai K, Banerjee S, Akira S; et al. (2000). "Caspase-1 activation of IL-1beta and IL-18 are essential for Shigella flexneri-induced inflammation". Immunity. 12 (5): 581–90. PMID 10843390.
  10. ↑ Sansonetti PJ, Ryter A, Clerc P, Maurelli AT, Mounier J (1986). "Multiplication of Shigella flexneri within HeLa cells: lysis of the phagocytic vacuole and plasmid-mediated contact hemolysis". Infect Immun. 51 (2): 461–9. PMC 262354. PMID 3510976.
  11. ↑ Bernardini ML, Mounier J, d'Hauteville H, Coquis-Rondon M, Sansonetti PJ (1989). "Identification of icsA, a plasmid locus of Shigella flexneri that governs bacterial intra- and intercellular spread through interaction with F-actin". Proc Natl Acad Sci U S A. 86 (10): 3867–71. PMC 287242. PMID 2542950.
  12. ↑ Girardin SE, Boneca IG, Carneiro LA, Antignac A, Jéhanno M, Viala J; et al. (2003). "Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan". Science. 300 (5625): 1584–7. doi:10.1126/science.1084677. PMID 12791997.
  13. ↑ Fasano A, Noriega FR, Liao FM, Wang W, Levine MM (1997). "Effect of shigella enterotoxin 1 (ShET1) on rabbit intestine in vitro and in vivo". Gut. 40 (4): 505–11. PMC 1027126. PMID 9176079.
  14. ↑ Cherla RP, Lee SY, Tesh VL (2003). "Shiga toxins and apoptosis". FEMS Microbiol Lett. 228 (2): 159–66. PMID 14638419.


Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Shigellosis_pathophysiology&oldid=1359519"